Dr. Kiran Kakarala, MD

Dr. Kakarala practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Kakarala's NPI, 1497882849, was assigned on February 27, 2007. Dr. Kakarala graduated from Harvard Medical School in 2006. Dr. Kakarala holds Ohio license 35097387.

Dr. Kakarala's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Kakarala's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Kakarala is also affiliated with The University of Kansas Health System Olathe Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Kakarala to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kakarala practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Kakarala's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Kakarala is licensed in Ohio.

CMS data shows 831 Medicare services from Dr. Kakarala across 16 procedure codes in 2024, for 442 Medicare patients. Medicare paid $186,090 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 442 Medicare patients who saw Dr. Kakarala in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kakarala's median patient age at 71, with 38% women.

In 2024, Dr. Kakarala wrote 162 Medicare Part D claims for 66 patients. 96% of them were for generic drugs. CMS names the drug for 82 of them, across 4 drugs with 11 or more claims each, at $2,007 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kakarala for performance year 2024, reported through an alternative payment model (APM). Dr. Kakarala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of melanoma (skin cancer) excision by Dr. Kakarala, more than 77% of the clinicians it reports for that procedure.

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 63 papers to Dr. Kakarala, published from 2010 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Free Tissue Flaps. Dr. Kakarala has published most often in Head Neck. Dr. Kakarala's most frequent co-authors are Terance T. Tsue, MD, Gregory N. Gan, MD, PhD and Andrew J. Holcomb, MD.

CMS Open Payments shows 37 general payments to Dr. Kakarala from 8 drug and device companies from 2016 to 2025. Education make up the largest share, 59% of the total. Intuitive Surgical, Inc. paid the most, $7,277.

Dr. Kakarala graduated from Harvard Medical School in 2006.